Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anne M Remes

Showing results (111-120 of 136) with videos related to

Pageof 14
Sort By:
Alzheimer'S Research & Therapy|October 10, 2022
Serum total TDP-43 levels are decreased in frontotemporal dementia patients with C9orf72 repeat expansion or concomitant motoneuron disease phenotypeKasper Katisko, Nadine Huber, Tarja Kokkola, et al.
Journal of Neurology|July 13, 2021
Safety of alemtuzumab in a nationwide cohort of Finnish multiple sclerosis patientsIlkka Rauma, Tiina Mustonen, Juha Matti Seppä, et al.
Journal of Alzheimer'S Disease : JAD|September 29, 2019
Low Serum High-Density Lipoprotein Cholesterol Levels Associate with the C9orf72 Repeat Expansion in Frontotemporal Lobar Degeneration PatientsOlli Jääskeläinen, Eino Solje, Anette Hall, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|June 30, 2021
GFAP as a biomarker in frontotemporal dementia and primary psychiatric disorders: diagnostic and prognostic performanceKasper Katisko, Antti Cajanus, Nadine Huber, et al.
Neuroimage. Clinical|July 1, 2017
Five-class differential diagnostics of neurodegenerative diseases using random undersampling boostingTong Tong, Christian Ledig, Ricardo Guerrero, et al.
Dementia and Geriatric Cognitive Disorders Extra|April 3, 2018
Automatic MRI Quantifying Methods in Behavioral-Variant Frontotemporal Dementia DiagnosisAntti Cajanus, Anette Hall, Juha Koikkalainen, et al.
Journal of the Neurological Sciences|August 20, 2016
Familial idiopathic normal pressure hydrocephalusJoel Huovinen, Sami Kastinen, Simo Komulainen, et al.
Plos One|January 16, 2020
Selection of memory clinic patients for CSF biomarker assessment can be restricted to a quarter of cases by using computerized decision support, without compromising diagnostic accuracyHanneke F M Rhodius-Meester, Ingrid S van Maurik, Juha Koikkalainen, et al.
Neuroimage. Clinical|February 12, 2019
Detecting frontotemporal dementia syndromes using MRI biomarkersMarie Bruun, Juha Koikkalainen, Hanneke F M Rhodius-Meester, et al.
Cortex; a Journal Devoted to the Study of the Nervous System and Behavior|October 30, 2021
Primary progressive aphasias associated with C9orf72 expansions: Another side of the storyDario Saracino, Amandine Géraudie, Anne M Remes, et al.
Pageof 14

Showing results (111-120 of 136) with videos related to

Sort By:
Pageof 14
Alzheimer'S Research & Therapy|October 10, 2022
Serum total TDP-43 levels are decreased in frontotemporal dementia patients with C9orf72 repeat expansion or concomitant motoneuron disease phenotypeKasper Katisko, Nadine Huber, Tarja Kokkola, et al.
Journal of Neurology|July 13, 2021
Safety of alemtuzumab in a nationwide cohort of Finnish multiple sclerosis patientsIlkka Rauma, Tiina Mustonen, Juha Matti Seppä, et al.
Journal of Alzheimer'S Disease : JAD|September 29, 2019
Low Serum High-Density Lipoprotein Cholesterol Levels Associate with the C9orf72 Repeat Expansion in Frontotemporal Lobar Degeneration PatientsOlli Jääskeläinen, Eino Solje, Anette Hall, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|June 30, 2021
GFAP as a biomarker in frontotemporal dementia and primary psychiatric disorders: diagnostic and prognostic performanceKasper Katisko, Antti Cajanus, Nadine Huber, et al.
Neuroimage. Clinical|July 1, 2017
Five-class differential diagnostics of neurodegenerative diseases using random undersampling boostingTong Tong, Christian Ledig, Ricardo Guerrero, et al.
Dementia and Geriatric Cognitive Disorders Extra|April 3, 2018
Automatic MRI Quantifying Methods in Behavioral-Variant Frontotemporal Dementia DiagnosisAntti Cajanus, Anette Hall, Juha Koikkalainen, et al.
Journal of the Neurological Sciences|August 20, 2016
Familial idiopathic normal pressure hydrocephalusJoel Huovinen, Sami Kastinen, Simo Komulainen, et al.
Plos One|January 16, 2020
Selection of memory clinic patients for CSF biomarker assessment can be restricted to a quarter of cases by using computerized decision support, without compromising diagnostic accuracyHanneke F M Rhodius-Meester, Ingrid S van Maurik, Juha Koikkalainen, et al.
Neuroimage. Clinical|February 12, 2019
Detecting frontotemporal dementia syndromes using MRI biomarkersMarie Bruun, Juha Koikkalainen, Hanneke F M Rhodius-Meester, et al.
Cortex; a Journal Devoted to the Study of the Nervous System and Behavior|October 30, 2021
Primary progressive aphasias associated with C9orf72 expansions: Another side of the storyDario Saracino, Amandine Géraudie, Anne M Remes, et al.
Pageof 14